Dr. Tom Inglesby, director of the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, will begin a temporary assignment in January as senior advisor for testing on the Biden Administration’s COVID-19 response team.
During the COVID-19 pandemic, Dr. Inglesby has provided technical guidance to response efforts at the global, federal, state, and local level. He has given analysis and expert testimony to policymakers, business leaders, and health organizations on public health interventions needed to control the pandemic. Dr. Inglesby served on the Maryland Governor’s COVID-19 Response Advisory Committee, the COVID Collaborative’s National Advisory Council, and as a commissioner on the National Commission on COVID-19 and Criminal Justice.
In 2020, he served on the Biden-Harris transition team reviewing HHS and advising on COVID-19 policy. In 2021, Dr. Inglesby served as senior policy advisor for the COVID-19 response in the Office of the U.S. Health and Human Services Secretary (HHS).
“Tom is a highly valued member of our HHS team and we look forward to continuing our partnership with Tom as he advances the Biden-Harris Administration’s work to expand testing as part of the White House COVID-19 response team,” said HHS Secretary Xavier Becerra. “Tom’s work is recognized not only in the U.S. but around the world for his work in public health and pandemic preparedness. At HHS, he has played a critical role in identifying how to help communities who need the most help in our work to mitigate COVID-19. His talent for quickly assessing new data and science to determine the best path forward has routinely been an asset to the Administration at large. With Tom at the White House, our nation will continue to benefit from his expertise as we tackle the pandemic.”
Dr. Inglesby’s work is internationally recognized in the fields of public health preparedness, pandemic and emerging infectious disease, and prevention of and response to biological threats. He was Chair of the Board of Scientific Counselors for the Center for Preparedness and Response at the US Centers for Disease Control and Prevention (CDC) from 2010 to 2019. He was Chair of the National Advisory Council of the Robert Wood Johnson Foundation’s National Health Security Preparedness Index. He was also a member of the CDC Director’s External Laboratory Safety Workgroup, which examined biosafety practices of the CDC, the National Institutes of Health, and the Food and Drug Administration following high-profile laboratory incidents in federal agencies. He has served as advisor to US Department of Health and Human Services (HHS), US Department of Defense, and US Department of Homeland Security on preparedness and response issues, and he has testified before Congress on many occasions. He has served on a range of committees and panels of the National Academies of Sciences, Engineering, and Medicine.
Dr. Inglesby will return to his role at the Johns Hopkins Center for Health Security in spring 2022.
Sources: HHS, Johns Hopkins Bloomberg School of Public Health Center for Health Security
READ ALSO:
- The biosecurity benefits of genetic engineering attribution Nature Communications
- Preparing for the Next Pandemic Hopkins Bloomberg Public Health
- How Serious is Coronavirus? Dr. Tom Inglesby Weighs In WETA
- ‘I have real serious concerns’: Trump’s comments about coronavirus prompted this Johns Hopkins official to speak out Baltimore Sun
- Building the global vaccine manufacturing capacity needed to respond to pandemics Center for Health Security
- United States–India Strategic Dialogue on Biosecurity – Report from the Seventh Dialogue Session Center for Health Security
- Developing a National Strategy for SARS-CoV-2 Serosurveys in the United States Center for Health Security
